Treatment for Co-Occurring Stimulant and Opioid Use Disorders-Reference-Cited by-同舟云学术

Treatment for Co-Occurring Stimulant and Opioid Use Disorders

Published:2024-09-01 Issue:9 Volume:81 Page:853
ISSN:2168-622X
Container-title:JAMA Psychiatry
language:en
Short-container-title:JAMA Psychiatry

Author:

Howell Benjamin A.¹²,Lin Lewei (Allison)³⁴,Coughlin Lara N.³

Affiliation:

1. Yale Program in Addiction Medicine, Department of Medicine, Yale School of Medicine, New Haven, Connecticut

2. Section of General Internal Medicine, Department of Medicine, Yale School of Medicine, New Haven, Connecticut

3. Michigan Innovations in Addiction Care through Research and Education, Department of Psychiatry, University of Michigan, Ann Arbor

4. Center for Clinical Management Research, VA Ann Arbor Healthcare System, Ann Arbor, Michigan

Abstract

This Viewpoint explores the current barriers to implementing contingency management treatment for individuals experiencing both opioid use and stimulant use disorders in the context of high numbers of US overdoses.

Publisher

American Medical Association (AMA)

Link

https://jamanetwork.com/journals/jamapsychiatry/articlepdf/2821074/jamapsychiatry_howell_2024_vp_240011_1724351293.93857.pdf

Reference10 articles.

1. Drug overdose deaths in the United States, 2001–2021.;Spencer;NCHS Data Brief,2022

2. Bupropion and naltrexone in methamphetamine use disorder.;Trivedi;N Engl J Med,2021

3. “Like yin and yang”: perceptions of methamphetamine benefits and consequences among people who use opioids in rural communities.;Baker;J Addict Med,2021

4. The dissemination and implementation of contingency management for substance use disorders: a systematic review.;Oluwoye;Psychol Addict Behav,2020

5. Contingency management for patients receiving medication for opioid use disorder: a systematic review and meta-analysis.;Bolívar;JAMA Psychiatry,2021